Results 201 to 210 of about 307,106 (305)

Automated Tuberculosis Detection in Chest Radiographs: A Hybrid Deep Learning Framework for Clinical Decision Support

Applied AI Letters, Volume 7, Issue 2, June 2026.
A hybrid deep learning framework integrating VGG16, ResNet50, and DenseNet121 is proposed for automated tuberculosis detection from chest X‐ray images. Feature‐level fusion enhances robustness and generalization, achieving 97.4% accuracy across multiple public datasets, supporting reliable clinical decision‐making in resource‐limited healthcare ...
Md. Tahmid Hossain, Hrittik Mural, Monowar Wadud Hridoy   +2 more
wiley   +1 more source

Cost-utility analysis of stratified isoniazid dosing by NAT2 genotype compared with isoniazid standard regimen for new patients with pulmonary tuberculosis in Thailand. [PDF]

Front Public Health
Kantared M, Permsuwan U.
europepmc   +1 more source

Serious Infection in Crohn's Disease Patients Treated With Ustekinumab: US Food and Drug Administration Active Postmarket Risk Identification and Analysis in the Sentinel Initiative

Clinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1514-1521, June 2026.
The U.S. Food and Drug Administration (FDA) used an Active Postmarket Risk Identification and Analysis (ARIA) system to address a safety issue (serious infection) identified during clinical review of an application to market ustekinumab as a treatment for Crohn's disease (CD). FDA used an active‐comparator new‐user cohort design, data from six Sentinel
Joel L. Weissfeld, Geetha S. Iyer, Suna C. Seo, Andrew Giffin, Andrew L. Simon, Sheryl A. Kluberg, Emma R. Hoffman, Jamal T. Jones, Sarah K. Dutcher, Joyce A. Korvick   +9 more
wiley   +1 more source

Trends and age-period-cohort analysis of bacteriologically confirmed pulmonary tuberculosis: a population-based study in Hunan Province, China, 2009-2023. [PDF]

Front Public Health
Huang G, Wang Q, Zheng W, Liu J, Bai L, Liang J, Xu Z, Yu S, Wan Y, Liu X, Yao H, Ming H.   +11 more
europepmc   +1 more source

No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjects

International Journal of Cancer, Volume 158, Issue 11, Page 2920-2927, 1 June 2026.
What's new? Venous thromboembolism (VTE) is common in cancer patients, with direct oral anticoagulants, including rivaroxaban, recommended as first‐line therapy. However, oral anticoagulant use is limited due to the growing use of targeted therapy and concerns about drug‐drug interactions.
Esther M. Hollander, Alessandra I. G. Buma, Jenneke Leentjens, Paddy K. C. Janssen, Michel M. van den Heuvel, David M. Burger, Berber Piet, Rob ter Heine   +7 more
wiley   +1 more source

Right Temporal Lobe Tuberculoma Presenting as Seizures in a Patient With Pulmonary Tuberculosis. [PDF]

Am J Case Rep
Rajanna S, Prasad S, Shaji M, Mehta K, Hassoun P, McSharry D, Lo A, Elias S, Tran HH.   +8 more
europepmc   +1 more source

Pulmonary Tuberculosis

, 2020
openaire   +2 more sources

What Difference Does Language Make? Comparing Systematic Evidence Reviews of Vietnamese and English Language Literatures on Climate Change and the Health of Outdoor Workers

Area, Volume 58, Issue 2, June 2026.
Short Abstract This paper compares two systematic literature reviews—one in English and one in Vietnamese—to examine how language shapes the production and framing of knowledge on climate change and health. It highlights significant differences in methods, assumptions and policy framings, and argues that linguistic boundaries are not just technical ...
Anh Ngoc Vu, Jonathan Rigg, Felicity Kersting, Ekaterina Tarnovskaya, Loc Duc Nguyen   +4 more
wiley   +1 more source

Endobronchial tuberculosis with atypical radiological images and features in association with long-term use of inhaled corticosteroid for bronchial asthma: lessons from the case and literature review. [PDF]

Respir Med Case Rep
Ikeda S, Hosomi Y.
europepmc   +1 more source

Immune endotypes in tuberculosis: Keys to decoding disease complexity

Journal of Internal Medicine, Volume 299, Issue 6, Page 670-693, June 2026.
Abstract Tuberculosis (TB) remains a major global health challenge, with multi‐drug antibiotic regimens as the current standard of care. While effective at killing Mycobacterium tuberculosis, these treatments do not resolve persistent inflammation, prevent lung damage, or reverse immune dysregulation that contribute to poor outcomes and disease ...
Shamila D. Alipoor, Julia Guthrie, Lina Davies Forsman, Andrew R. Di Nardo, Susanna Brighenti   +4 more
wiley   +1 more source